Canada \u00b7 Semaglutide generics
Generic semaglutide in Canada: what Health Canada has authorized.
Short answer
Canada is the first G7 country with generic semaglutide. Health Canada authorized Dr. Reddy's generic Ozempic on April 28, 2026, then Apotex's on May 1, 2026, and the first generic Wegovy, Apotex's Sevmia, on June 29, 2026. Sandoz announced its authorization on September 18, 2026. All require a prescription. This page does not list prices, pharmacies or doses.
Generic semaglutide products in the Drug Product Database
As listed in Health Canada's Drug Product Database in October 2026:
| Product | Company | Generic of | Authorized for |
|---|---|---|---|
| Semaglutide Injection | Dr. Reddy's | Ozempic | Type 2 diabetes |
| Apo-Semaglutide | Apotex | Ozempic | Type 2 diabetes |
| Sevmia | Apotex | Wegovy | Chronic weight management |
| Sandoz Semaglutide | Sandoz | Ozempic | Type 2 diabetes |
| Aspen-Semaglutide / Semaglutide Injection | Aspen | Ozempic | Type 2 diabetes |
Being authorized does not mean every product is stocked everywhere yet. Check the database or ask a pharmacist for current status.
Generic vs brand: what changes
A Health Canada-authorized generic has the same active ingredient and must meet the department's criteria for safety, efficacy and quality. Pens, instructions and coverage can differ, so a switch is worth a conversation with your prescriber or pharmacist. Side effects are the same as with the brand — see Ozempic side effects in Canada.
What semaglutide users report
- 37 published anonymous Semaglutide confessions; 5 mention at least one side effect.
- Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.
Most-mentioned side effects (share of Semaglutide confessions):
- Burping: 5.4% (2)
- Nausea: 5.4% (2)
- Vomiting: 5.4% (2)
- Anxiety or panic: 2.7% (1)
- Constipation: 2.7% (1)
Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: Semaglutide hub.
Generic vs brand at a glance
| Brand | Generic | |
|---|---|---|
| Active ingredient | Semaglutide | Same |
| Health Canada review | Full | Shown equivalent to brand |
| Side effects | Same | Same |
| Device | Brand pen | May differ; ask your pharmacist how to use it |
Last reviewed October 15, 2026against Health Canada's Drug Product Database and Health Canada sources.
Related
Frequently asked questions
- Will a generic semaglutide pen work the same way?
- The medicine is equivalent, but the pen may differ; ask your pharmacist to show you the device.
- Is there a generic semaglutide in Canada?
- Yes. Canada was the first G7 country to authorize one: Dr. Reddy's generic Ozempic on April 28, 2026, then Apotex's Apo-Semaglutide on May 1, 2026. Sandoz and Aspen versions also appear in Health Canada's Drug Product Database.
- Is there a generic Wegovy in Canada?
- Yes. Health Canada authorized Apotex's Sevmia, a generic of Wegovy for chronic weight management, on June 29, 2026.
- Is generic semaglutide approved for weight loss?
- The generic Ozempic versions are authorized for type 2 diabetes. Sevmia is the generic authorized for weight management. Off-label prescribing is a decision for your prescriber.
- Is there a generic Mounjaro in Canada?
- No. As of October 2026, Health Canada's Drug Product Database lists tirzepatide only under Eli Lilly's Mounjaro and Zepbound.
- Do I need a prescription for generic semaglutide?
- Yes. Brand or generic, semaglutide is a prescription drug in Canada. Authorized products carry a Drug Identification Number (DIN).
- Does this page list prices or pharmacies?
- No. We do not publish prices, sellers or dosing. Ask a pharmacist about coverage and cost.
General information only — not medical, legal or regulatory advice. Peptide Confessions does not sell, source or recommend any product or vendor, and nothing here is dosing guidance. Speak with a licensed Canadian healthcare professional or pharmacist about any medication. Editorial process →